5-(3-fluorophenyl)-4H-1,2,4-triazol-3-amine, 95.0%, 5g

2-Bromo-5-fluoroisonicotinic acid, 95.0%, 5g

Ethyl 5-chloro-1,3,4-thiadiazole-2-carboxylate, 95.0%, 25g

3-(5-Methyl-tetrazol-1-yl)-phenylamine, 95.0%, 10g

GC capillary column ROTI®Cap-5, 10 m, 0.53 mm, 5.00 µm, 1 Piece(s)

tert-Butyl 2-(methylthio)-5,8-dihydropyrido[3,4-d]pyrimidine-7(6H)-carboxylate, 98+%, 1g

1-Hexyl-3-methylimidazolium Tetrafluoroborate, 95%, 500g

Ethyl 4-fluorophenylacetate, 95.0%, 25g

(2-methyl-1H-imidazol-1-yl)acetonitrile, 95.0%, 5g

3-(4-FLUOROPHENYL)AZETIDINE HCL, 95.0%, 250mg

tert-Butyl 2-hydroxypyrrolidine-1-carboxylate, 95.0%, 10g

1-[(2R,3S,4R,5R)-3,4-bis(benzoyloxy)-2-[(benzoyloxy)methyl]-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]triaz-2-yn-2-ium-1-ide, 97%, 1g

Ethyl 4-Iodophenylacetate, 98.0%, 1g